News | July 22, 2023
Lonza delivers 5.6% CER sales growth and 30% CORE EBITDA margin
Good momentum in commercial CDMO business
Good momentum in commercial CDMO business
First of its kind screening for Glaucoma at grass root level over 10k screened already
Approval to dramatically change CAR-T therapies landscape
Alembic has a cumulative total of 184 ANDA approvals (159 final approvals and 25 tentative approvals) from USFDA.
The VITA-FAST tokens have been met with overwhelming interest
Under the terms of the collaboration, Vertex and Lonza will partner in the process development and scale-up for the manufacturing of the product portfolio and co-invest to build a dedicated new facility in Portsmouth, New Hampshire (US)
Antimicrobial Resistance (AMR) poses a significant threat to global healthcare systems and patient safety
This product will be manufactured at Lupin's Pithampur facility in India
The partnership aims to prioritize the diagnosis and treatment of these diseases while working to reducing their long-term prevalence
The application is in line with Innocan's strategy to expand the scope of its combined magnesium and cannabis topical solution
Subscribe To Our Newsletter & Stay Updated
